Altimmune, Inc.

Altimmune, Inc.

Altimmune, Inc.

Altimmune, Inc. is a clinical stage biotechnology company developing nextgeneration immunotherapeutics and vaccines to address significant public health and biodefense needs.
Founded
1997
Raised
$16.9M
Follow us
Alexa global traffic share
Latest funding
$16,900,000
Venture capital - 2018
Team Size
10+
Employees
$16,900,000 Venture capital
FinSMEs

Altimmune Closes on $16.9M in Funding

Apps & Services